Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
Voice of America - September 6, 2007
Noel King
Kigali, Rwanda
An estimated 190,000 people in Rwanda, about three percent of the population, are infected with HIV and AIDS. But there is optimism at the highest levels of government that education can stem the spread of disease. Noel King reports from Kigali that officials also hope generic anti-retroviral drugs from Canada may drastically improve the lives of many affected by HIV/AIDS.
Rwandan officials announced their intent to import generically made HIV/AIDS medications manufactured in Canada, last July.
Medical authorities in Rwanda have not yet approved the drugs for public consumption; but they acknowledge that cheaply made drugs could have a tremendous effect on this developing nation.
Executive Secretary of Rwanda 's National AIDS Control Commission, Agnes Binagwaho, spoke to VOA in Kigali. She said generic drugs could benefit impoverished people living with the disease.
"For changing the life of people living with HIV/AIDS, there will be no doubt," she said. "If those are good drugs, cheap drugs. The cheaper it is, the more people we can put on treatment with the same amount of money. It can change the future."
Rwanda is the first country to take advantage of a World Health Organization waiver that allows poor countries to work around patent laws and import generic drugs that cannot be manufactured domestically.
Binagwaho said Rwanda has also made great strides with campaigns aimed at educating the public on condom use and urging compassion for those who are ill.
Rwandan national surveys indicate HIV/AIDS patients are rarely stigmatized, although many people prefer to live with the disease in secret.
Binagwaho notes that Rwanda has also chosen to directly address the problem of female sex workers.
"What we try to do, we try to pull them out of prostitution, give them another way to have [an] income so that those women can work, real work and do not sell their bodies to have money. And it works," she said.
U.S. aid to Rwanda to tackle HIV/AIDS increased 31 percent to almost $103 million in 2007.
Challenges still loom though, as an influx of formerly displaced Rwandans have returned home from Tanzania with high rates of disease.
It is unclear what impact the flood of refugees fleeing violence in neighboring Democratic Republic of Congo, will have on HIV/AIDS rates in Rwanda.
070906
VA070904
Copyright © 2007 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .